Viewing nowLansoprazole Capsule 30 mg (Lansoprazole)
Lansoprazole 30mg
Hard capsule · Prescription medication
Samchundang Pharmaceutical Co., Ltd.

MFDS item code 201110631 · Notified 2011.12.05 · Insurance code 651203740
Treatment of gastric and duodenal ulcers, Helicobacter pylori infection, reflux disease, and gastric acid hypersecretion
This medication is used for the short-term treatment of active duodenal ulcers and active benign gastric ulcers. It also helps eradicate Helicobacter pylori to prevent the recurrence of duodenal ulcers, and can be used in maintenance therapy after treatment. It is effective for treating gastric ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs) and reducing the risk of occurrence. It is also used for the symptoms of gastroesophageal reflux disease and erosive esophagitis, and helps improve conditions with pathological hypersecretion of gastric acid, such as Zollinger-Ellison syndrome. Thus, this medication is used to treat and improve various symptoms and pathological states associated with gastrointestinal diseases.
This medicine should be administered before meals. For patients who have difficulty swallowing the medicine, open the capsule, mix the contents with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. To ensure the full dose is administered, rinse the glass with twice or more juice and drink immediately. After opening this medicine, do not chew or crush it before taking it. Short-term treatment of active duodenal ulcers: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer recurrence: Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if needed. Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer recurrence: Administer lansoprazole 30 mg in combination with amoxicillin 1,000 mg three times daily (every 8 hours) for 14 days. Maintenance therapy following treatment of duodenal ulcers: Administer lansoprazole 15 mg orally once daily. The duration of comparative clinical trials did not exceed 12 months. Treatment of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. The duration of comparative clinical trials did not exceed 8 weeks. Reduction of the risk of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 15 mg orally once daily for 12 weeks. The duration of comparative clinical trials did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease: Administer lansoprazole 15 mg orally once daily for 8 weeks Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance therapy following treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome: The lansoprazole dosage for pathological hypersecretory conditions varies for each patient. The usual starting dose for adults is 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued for as long as it is clinically effective. Doses of 90 mg per dose up to twice daily have been administered. If the daily dose exceeds 120 mg, it should be administered in divided doses. Because clearance of this medicine is reduced in elderly patients, dose adjustment is required. Do not exceed a daily dose of 30 mg. In patients with hepatic impairment, metabolism and excretion of this medicine may be delayed; administer with caution, including dose adjustment as appropriate.
Children and adolescents 12 ∼ 17 years — Short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents 12 ∼ 17 years — Short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children 1 ∼ 11 years, 30 kg or less — Short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis: 15 mg once daily for 12 weeks Children 1 ∼ 11 years, over 30 kg — Short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis: 30 mg once daily for 12 weeks
This medication should not be used by patients who are allergic to certain ingredients. Care should be taken in particular for those with hypersensitivity to benzimidazoles or penicillins, as well as macrolide antibiotics. It is advisable for pregnant or breastfeeding women to avoid this medication. Caution is required in patients with compromised liver or kidney function, elderly patients, and children. Serious allergic reactions such as anaphylaxis, skin rash, and breathing difficulties may occur, so careful monitoring is necessary during treatment. Serious side effects, such as liver dysfunction, blood disorders, and acute interstitial nephritis, may occur; if any abnormal symptoms appear, discontinue use immediately and consult a healthcare provider. Common side effects such as diarrhea, headache, and abdominal pain may also occur, so it is advisable to inform a healthcare provider if these symptoms develop. Long-term use may result in vitamin B12 deficiency or hypomagnesemia, necessitating regular testing. This medication suppresses gastric acid secretion, which may slightly increase the risk of gastrointestinal infections. Many drug interactions are possible, so it is essential to inform healthcare providers particularly if taking antibiotics, anticoagulants, immunosuppressants, or antifungals. Dizziness, drowsiness, or visual disturbances may occur; caution is necessary when driving or operating machinery. Dosage adjustment and caution are necessary for children and the elderly, and immediate consultation with healthcare providers is required in cases of overdose. Store in a container that is tightly closed and not accessible to children, and do not transfer to another container.
Anaphylactic reactions, generalized rash, facial swelling, dyspnea, shock, pancytopenia, agranulocytosis, hemolytic anemia, neutropenia, thrombocytopenia, anemia, jaundice, elevated AST, elevated ALT, toxic liver dysfunction, toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS syndrome, interstitial pneumonia, interstitial nephritis, acute renal failure, membranous colitis, abdominal pain, diarrhea, headache, abdominal distension, allergic reactions, back pain, weakness, candidiasis, neoplasms, chills, chest pain, edema, fever, flu-like symptoms, halitosis, infection, malaise, neck stiffness, pelvic pain, angina pectoris, arrhythmia, bradycardia, tachycardia, cerebrovascular accident, cerebral infarction, hypertension, hypotension, migraine, myocardial infarction, palpitations, vasodilation, syncope, asthma, bronchitis, increased cough, epistaxis, hemoptysis, hiccups, pneumonia, upper respiratory tract infection, laryngeal tumor, pulmonary fibrosis, pharyngitis, pleural disorders, respiratory disorders, rhinitis, sinusitis, wheezing, acne, hair loss, pruritus, rash, urticaria, contact dermatitis, dry skin, nail disorders, skin cancer, skin disorders, sweating, abnormal vision, amblyopia, blepharitis, cataract, conjunctivitis, dry eye, ear disorders, eye disorders, glaucoma, abnormal olfaction, photophobia, retinal degeneration, loss of taste, blurred vision, deafness, eye pain, otitis media, taste disorder, tinnitus, visual field constriction, urinary disorders, renal pain, penile disorders, testicular disorders, urethral pain, polyuria, urinary frequency, urinary retention, menstrual irregularities, chest tenderness, chest expansion, gynecomastia, diabetes, hematuria, erectile dysfunction, nephrolithiasis, hepatotoxicity, pancreatitis, taste abnormalities, aplastic anemia, leukopenia, thrombotic thrombocytopenic purpura, eosinophilia, hypomagnesemia, Clostridium difficile-associated diarrhea, fractures, myositis, erythema multiforme, speech disorders, urinary retention, elevated AST, elevated ALP, elevated LDH, elevated γ-GTP, weakness, hyponatremia, increased total cholesterol, decreased total cholesterol, tongue paralysis, lip paralysis, limb paralysis, constipation, dizziness, nausea, vomiting, gastrointestinal bleeding, appetite loss, bezoar, pyloric spasm, cholelithiasis, constipation, thirst, dry mouth, dyspepsia, dysphagia, belching, esophageal stricture, esophageal ulcer, esophagitis, discolored stools, abdominal distension, gastric nodules, gastric submucosal polyps, gastroenteritis, gastric-duodenal bleeding, hematemesis, increased appetite, increased salivation, rectal bleeding, stomatitis, glossitis, gum bleeding, postprandial glucose, colitis, vomiting, diarrhea, gastrointestinal candidiasis, rectal disorders, rectal bleeding, diabetes mellitus, goiter, hypothyroidism, bleeding, lymphadenopathy, vitamin deficiency, gout, hyperglycemia, hypoglycemia, dehydration, weight gain, weight loss, peripheral edema, bone disorders, joint disorders, leg cramps, arthritis, arthralgia, musculoskeletal pain, myalgia, myasthenia, ptosis, synovitis, agitation, amnesia, anxiety, indifference, confusion, depression, syncope, hallucinations, unilateral paralysis, exacerbation of hostility, decreased libido, increased libido, neurosis, sensory disturbances, abnormal thought processes, convulsions, dementia, depersonalization, diplopia, hyperactivity, hypertonia, sensory loss syndrome, insomnia, sleep disorders, drowsiness, tremors, subacute cutaneous lupus erythematosus, systemic lupus erythematosus, discoid lupus erythematosus, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, eosinophilia, drug reaction with systemic symptoms, severe cutaneous adverse reactions
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and it should be kept at room temperature between 1 and 30 degrees Celsius. Proper storage will maintain the effectiveness and prevent degradation of the medication.
A hard capsule with white to light brown granules.
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLansoprazole 30mg
Hard capsule · Prescription medication
Samchundang Pharmaceutical Co., Ltd.

Lansoprazole 15mg
Hard capsule · Prescription medication
Korea Pharmaceutical Co., Ltd.

Lansoprazole 15mg
Orally disintegrating Tablet · Prescription medication
Takeda Pharmaceuticals Korea Co., Ltd.

Lansoprazole 30mg
Orally disintegrating Tablet · Prescription medication
Takeda Pharmaceuticals Korea Co., Ltd.
Lansoprazole 15mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Lansoprazole 30mg
Hard capsule · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.
Lansoprazole 30mg
Hard capsule · Prescription medication
Aprogen Biologics Co., Ltd.

Lansoprazole 15mg
Hard capsule · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.